Aster DM Q1 FY27: Revenue up 18.4%, Rs 14.3 cr loss on merger costs
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Smallcap 250 and 0.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aster DM Quality Care (formerly Aster DM Healthcare) Q1 FY27 standalone results: Revenue from operations rose 18.4% to Rs 725.73 cr (vs Rs 613.04 cr YoY). Profit before exceptional items grew to Rs 120.68 cr (vs Rs 112.42 cr). However, Rs 109.79 cr merger-related exceptional costs cut PBT to Rs 10.89 cr, resulting in a net loss of Rs 14.30 cr versus profit of Rs 80.59 cr YoY. EPS turned negative at Rs -0.28. Name changed post NCLT-approved merger with Quality Care India, effective 1 July 2026.
Headline net loss driven by one-time merger costs, not operations. Underlying business remains strong with healthy revenue and operating profit growth.